Gilead Sciences, Lda. secures contract for Acquisition Of Liposomical Amphotericin Drug [50Mg; Iv; F/Amp] For Ulscb

Portugal, Sept. 15 -- Portugal based Gilead Sciences, Lda. has secured contract from Unidade Local De Saude De Castelo Branco, E. P. E. for Acquisition Of Liposomical Amphotericin Drug [50Mg; Iv; F/Amp] For Ulscb. The value of the contract is worth 3438150 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....